Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat

Journal of Neurotrauma

Volumn 15, Issue 7, 1998, Pages 473-484

  Dora, Chandler D ^a   Koch, Sebastian ^b   Sanchez, Arnaldo ^a   Ruenes, Gladys ^a   Liu, Shanliang ^a   Yezierski, Robert P ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Ischemia; Neuroprotection; Nitric oxide; Spinal cord injury

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; INTRASPINAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD BLOOD FLOW; SPINAL CORD INJURY; SPINAL CORD NERVE CELL;

EID: 0031837374     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1998.15.473     Document Type: Article

References (74)

1. ADEN, U., LINDSTROM, K., BONA, F., HAGBERG, H., and FREDHOLM, B.B. (1994). Changes in adenosine receptors in the neonatal rat following hypoxic ischemia. Brain Res. 23, 354-358.
2. ALEXANDER, S., and KERR, F.W.L. (1964). Blood pressure responses in acute compression of the spinal cord. J. Neurosurg. 21, 485-491.
3. ANDERSON, D.K., and HALL, E.D. (1994). Lipid hydrolysis and free radical formation in the central nervous system, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: NY, pps. 131-138.
4. ANDERSON, D.K., MEANS, T.D., and WATERS, T.R. (1982). Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J. Neurosurg. 56, 106-113.
5. + in the contribution of adenosine to hypoxia-induced pial artery dilation. J. Cereb. Blood Flow Metab. 17, 100-108.
6. BEAL, M.F. (1997). Therapeutic effects of nitric oxide synthase inhibition in neuronal injury, in: Neuroprotection in CNS Diseases. P.R. Bar and M. Flint Beal (eds), Marcel Dekker, Inc.: NY, pps. 131-145.
7. BETHEA, J.R., CASTRO, M., LEE, T.T., DIETRICH, W.D., and YEZIERSKI, R.P. (1998). Traumatic spinal cord injury induces nuclear factor kappa-B activation. J. Neurosci. 18, 3251-3260.
8. BINGHAM, W.G., GOLDMAN, H., FRIEDMAN, S.J., MURPHY, S., and YASHON, D. (1975). Blood flow in normal and injured monkey spinal cord. J. Neurosurg. 43, 162-171.
9. BLACK, P., MARKOWITZ, R.S., FINKELSTEIN, S.D., MCMONAGLE-STRUCKO, K., and GILLESPIE, J.A. (1988). Experimental spinal cord injury: effect of a calcium channel antagonist (nicardipine). Neurosurgery 22, 61-66.
10. BLOCK, G.A., and PULSINELLI, W.A. (1987). The adenosine agonist R-phenylisopropyladenosine attenuates ischemic neuronal damage. J. Cereb. Blood Flow Metabl. 7, S258.
11. BLOT, S., ARNAL, J.F., XU, Y., GRAY, F., and MICHEL, J.B. (1994). Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke 25, 1666-1673.
12. BRACKEN, M.B., SHEPARD, M.J., and COLLINS, W.F. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322, 1405-1411.
13. BRACKEN, M.B., SHEPARD, M.J. COLLINS, W.F., et al. (1992). Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow up data. J. Neurosurg. 58, 538-542.
14. CANTOR, S.L., ZORNOW, M.H., MILLER, L.P., and YAKSH, T.L. (1992). The effect of cyclohexyladenosine on the periischemic increases of hippocampal glutamate and glycine in the rabbit. J. Neurochem. 59, 1884-1892.
15. COLLIS, M.G. (1989). The vasodilator role of adenosine. Pharmacol. Ther. 42, 143-162.
16. CORRADETTI, R., LO CONTE, G., MORONI, F., PASSANI, M.B., and PEPEU, G. (1984). Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104, 19-26.
17. DAWSON, D.A. (1994). Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. Brain Metab. Rev. 6, 299-324.
18. DIMARCO, J.P., SELLERS, T.D., BERNE, R.M., WEST, G.A., and BELARDINELLI, L. (1983). Adenosine: electrophysiologic effects and therapeutic use for terminating paroxsymal supraventricular tachycardia. Circulation 68, 1254-1263.
19. DOLPHIN, A.C., and ARCHER, E.R. (1983). An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett. 43, 49-54.
20. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acid receptors and NMDA receptors in traumatic brain injury. Science 244, 798-800.
21. FADEN, A.I., JACOBS, T.P., and MOUGEY, E. (1981). Endorphins in experimental spinal cord injury: therapeutic effect of naloxone. Ann. Neurol. 10, 326-332.
22. FAIRHOLM, D.J., and TURNBULL, I.M. (1971). Microangiographic study of experimental spinal cord injuries. J. Neurosurg. 35, 277-286.
23. 3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol. Scand. 125, 121-123.
24. FOWLER, J.C. (1993). Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices. Neurosci. Lett. 157, 83-86.
25. FREDHOLM, B.B. (1995). Adenosine receptors in the central nervous system. NIPS 10, 122-128.
26. FREDHOLM, B.B. (1997). Adenosine and neuroprotection. Int. Rev. Neurobiol. 40, 259-280.
27. FRIED, L.C., and GOODKIN, R. (1971). Microangiopathic observations of the experimentally traumatized spinal cord. J. Neurosurg. 35, 709-714.
28. GAO, Y., and PHILLIS, J.W. (1994). CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbil. Life Sci. 55, PL61-65.
29. GRIFFITHS, I.R. (1976). Spinal cord blood flow after acute experimental cord injury in dogs. J. Neurol. Sci. 27, 247-259.
30. GUHA, A., and TATOR, C.H. (1988). Acute cardiovascular effects of experimental spinal cord injury. J. Trauma 28, 481-490.
31. GUHA, A., TATOR, C.H., and ROCHON, J. (1989a). Spinal cord blood flow and systemic blood pressure after experimental spinal cord injury in rats. Stroke 20, 372-377.
32. GUHA, A., TATOR, C.H., and SMITH, C.R. (1989b). Improvement in post-traumatic spinal cord blood flow with a combination of a calcium channel blocker and a vasopressor. J. Trauma 29, 1440-1447.
33. HEROLD, J.A., LANGENBURG, S.E., BLACKBOURNE, L.H., and TRIBBLE, C.G. (1994). Complete prevention of postischemic spinal cord injury by of regional infusion with hypothermic saline and adenosine. J. Thorac. Cardiovasc. Surg. 107, 536-542.
34. HOLTZ, A., NYSTROM, B., and GERDIN, B. (1989). Spinal cord injury in rats: inability of nimodipine or anti-neutrophil serum to improve spinal cord blood flow or neurologic status. Acta Neurol. Scand. 79, 460-467.
35. HSU, C.Y., LIN, T-N., XU, J., CHAO, J., and HOGAN, E.L. (1994). Kinins and related inflammatory mediators in central nervous system injury, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: NY, pps. 145-154.
36. IADECOLA, C. (1993). Regulation of cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci. 16, 206-214.
37. ISHIKAWA, T., and MARSALA, M. (1996). Excitatory amino acids and prostanoids release in spinal cord injury. Brain Nerve 48, 259-263.
38. KALARIA, R.N., and HARIK, S.I. (1988). Adenosine receptors and the nucleoside transporter in human brain vasculature. J. Cereb. Blood Flow Metab. 8, 32-39.
39. KOBRINE, A.I., DOYLE, T.F., and MARTINS, T.N. (1976). Spinal cord blood flow as effected by changes in systemic arterial blood pressure. J. Neurosurg. 44, 12-15.
40. KULUZ, J.W., PRADO, R.J., DIETRICH, W.D., SCHLEIEN, C.L., and WATSON, B.D. (1993). The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24, 2023-2039.
41. LIPTON, S.A., and STAMLER, J.S. (1997). Neuronal injury or protection by nitric oxide-related species, in: Neuroprotection in CNS Diseases. P.R. Bar and M. Flint Beal (eds), Marcel Dekker, Inc.: NY, pps. 121-130.
42. LIU, S., RUENES, G.L., and YEZIERSKI, R.P. (1997). NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res. 756, 160-167.
43. MAKUJINA, S.R., SABOUNI, M.H., BHATIA, S., DOUGLAS, F.L., and MUSTAFA, S.J. (1992). Vasodilatory of adenosine A2 receptor agonists CGS 21680 and CGS 22492 in human vasculature. Eur. J. Pharmacol. 221, 243-247.
44. MONCADA, C., LEKIEFFRE, D., ARVIN, B., and MELDRUM, B. (1992). Effect of NO synthase inhibition on NMDA-and ischaemia-induced hippocampal lesions. Neuroreport 3, 530-532.
45. MILLER, L.P., and HSU, C. (1992). Therapeutic potential for adenosine receptor activation in ischemic brain injury. J. Neurotrauma 9, S563-577.
46. MIYASHITA, K., NAKAJIMA, T., ISHIKAWA, T., and MIYATAKE, T. (1992). An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemia. Neurochem. Res. 17, 147-150.
47. NOBLE, L.J. (1994). Anatomical assessment of spinal cord injury, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: NY, pps. 99-108.
48. O'NEILL, L.A.J., and KALTSCHMIDT, C. (1997). NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
49. PHILLIS, J.W., SMITH-BARBOUR, M., O'REGAN, and PERKINS, L.M. (1994). Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem. Res. 19, 1125-1130.
50. PROCTOR, W.R., and DUNWIDDIE, T.V. (1983). Adenosine inhibits calcium spikes in hippocampal pyramidal neurons in vitro. Neurosci. Lett. 35, 197-201.
51. REGAN, R., and CHOI, D.W. (1994). Excitotoxicity and central nervous system trauma, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: NY, pps. 173-181.
52. REPPERT, S.M., WEAVER, D.R., STEHLE, J., and RIVKEES, S.A. (1991). Molecular cloning and characterization of a rat A1 adenosine receptor that is widely expressed in brain and spinal cord. Mol. Endocrinol. 5, 1037-1048.
53. ROUSSEL, S., PINARD, E., and SEYLAZ, J. (1991). Focal cerebral ischemia in chronic hypertension: no protection by (R)-phenylisopropyladenosine. Brain Res. 545, 171-174.
54. SALTER, M.W., DEKONINCK, Y., and HENRY, J.L. (1993). Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog. Neurobiol. 41, 125-156.
55. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. J. Physiol. 435, 373-393.
56. SCIOTTI, V.M., ROCHE, F.M., GRABB, M.C., and VAN WYLEN, D.G.L. (1992). Adenosine receptor blockade augments interstitial fluid levels of excitatory amino acids during cerebral ischemia. J. Cereb. Blood Flow Metab. 12, 646-655.
57. SEIBEL, P.S., THEODORE, P., KRON, I.L., and TRIBBLE, C.G. (1993). Regional adenosine attenuates postischemic spinal cord injury. J. Vasc. Surg. 18, 153-160.
58. SENTER, H.J., and VENES, J.L. (1979). Loss of auto-regulation and post-traumatic ischemia following experimental spinal cord trauma. J. Neurosurg. 50, 198-206.
59. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
60. TOGASHI, H., SASAKI, M., FROHMAN, E., et al. (1997). Neuronal (type I) nitric oxide synthase regulates nuclear factor kB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. U.S.A. 94, 2676-2680.
61. TREMBLY, B. (1995). Clinical potential for the use of neuroprotective agents. Ann. N.Y. Acad. Sci. 765, 1-20.
62. TRUSSELL, L.O., and JACKSON, M.B. (1985). Adenosine-activated potassium conductance in cultured striatal neurons. Proc. Natl. Acad. Sci. U.S.A. 82, 4857-4861.
63. WALLACE, M.C., and TATOR, C.H. (1986a). Failure of blood transfusion or naloxone to improve clinical recovery after experimental spinal cord injury. Neurosurgery 19, 489-494.
64. WALLACE, M.C., and TATOR, C.H. (1986b). Failure of naloxone to improve spinal cord blood flow and cardiac output after spinal cord injury. Neurosurgery 18, 428-432.
65. WALLACE, M.C., TATOR, C.H., and FRAZEE, P. (1986c). Relationship between posttraumatic ischemia and hemorrhage in the injured rat spinal cord as shown by colloidal carbon angiography. Neurosurgery 18, 433-439.
66. WRATHALL, J.R. (1994). Behavioral analyses in experimental spinal cord trauma, in: The Neurobiology of Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: NY, pps. 79-85.
67. 2+ uptake by rat cortical synaptosomes. J. Neurochem. 39, 700-708.
68. YEZIERSKI, R.P., BUCHANAN, R., KOCH, S., BELMONT, H., and SANCHEZ, A. (1995). Effects of adenosine on neuronal damage produced by intraspinal or intrathecal injection of nitric oxide synthase inhibitor L-NAME. Soc. Neurosci. Abstr. 21, 998.
69. YEZIERSKI, R.P., LIU, S., RUENES, G.L., BUSTO, R., and DIETRICH, W.D. (1996). Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat. J. Cereb. Blood Flow Metab. 16, 996-1004.
70. YEZIERSKI, R.P., LIU, S., RUENES, G.L., KAJANDER, K.J., and BREWER, K.L. (1998). Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain 75, 141-155.
71. YEZIERSKI, R.P., and PARK, S.H. (1993). The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci. Lett. 157, 115-119.
72. YEZIERSKI, R.P., SANTANA, M., PARK, S.H., and MADSEN, P.W. (1993). Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. J. Neurotrauma 10, 445-456.
73. YOUNG, W. (1987). The post-injury responses in trauma and ischemia: secondary injury or protective mechanism? CNS Trauma 4, 27-52.
74. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 7432.